Homepage ASDReports
Your Cart Is Empty
Page 1 of 1 | 1 |
Report title   (click to sort results)

US$2,224.00
Jul 2010

The Global OTC Pharmaceutical Market 2010-2025

In 2009, the global over-the-counter (OTC) pharmaceutical market generated revenues of more than $60bn. Our analyses show that total OTC revenues will exceed $70bn by 2015. From 2010 onwards, Rx-to-OTC switching and the continuing importance of emerging healthcare markets will drive sales in this sector. Our forecasts reveal that the OTC pharma market will grow significantly from 2010 onwards. This report explains where future OTC switching and other developments will occur, providing you with the information that you need to understand the current OTC market and its future prospects.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$995.00
Aug 2009

OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

Datamonitor's OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$795.00
Aug 2009

OTC Pharmaceuticals - North America (NAFTA) Industry Guide

Datamonitor's OTC Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$795.00
Aug 2009

OTC Pharmaceuticals - Scandinavia Industry Guide

Datamonitor's OTC Pharmaceuticals - Scandinavia Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Scandinavian (Denmark, Norway and Sweden) countries. The report includes easily comparable data on market value, segmentation, and five forces analysis, plus full five year market forecasts for each country. It examines future problems, innovations and potential growth areas within the market.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$1,495.00
Aug 2009

OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide

Datamonitor's OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$2,224.00
May 2009

The Global OTC Pharmaceutical Market 2009-2024

General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report - The Global OTC Pharmaceutical Market 2009-2024 – visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Our forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that you need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$2,995.00
May 2009

OTC Pharmaceuticals: Extended Global Industry Guide

Datamonitor's OTC Pharmaceuticals: Extended Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$1,495.00
Apr 2009

OTC Pharmaceuticals: Global Industry Guide

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$5,700.00
Jun 2008

Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch

With the growing cost of developing novel drugs, combined with the fact that fewer such drugs are gaining regulatory approval, the use of lifecycle management is playing an ever-more important role in the increasingly cost-conscious pharma industry. Rx-to-OTC switching is one such strategy employed to either enhance existing franchise revenues or protect branded revenues from generic competition.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$2,224.00
Jun 2008

The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023

Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the market. Sources used include industrial databases, commercial and financial news, published reports and policy documents, interviews and questionnaires. Visiongain applied financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market-based report with detailed analysis and informed opinion. The report examines the worldwide OTC market, breaking down present and forecasted sales revenues into leading therapeutic categories and national markets. Visiongain also provides forecasts for leading OTC brands.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

US$1,495.00
Feb 2008

OTC Pharmaceuticals: Global Industry Guide

Datamonitor's OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Order NowAdd to cart  |   More InformationMore information  |   Tell-a-FriendTell a friend

Page 1 of 1 | 1 |

   ASD Reports - © 2008-2010 - contact us - terms & conditions - privacy policy